Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 4Phase 1 3Phase NA 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 2Central Nervous System Neoplasms 2Medulloblastoma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Glioma 1

Interventions

Magnetic Resonance Spectroscopy 16Blood Specimen Collection 8Temozolomide 5Magnetic Resonance Imaging 5Bevacizumab 4Yoga 3Radiotherapy, Intensity-Modulated 3Biopsy 3Transcranial Magnetic Stimulation 2Surveys and Questionnaires 2Restraint, Physical 2Radiosurgery 2Radiation 2Psychosocial Intervention 2Proton Therapy 2Physical Therapy Modalities 2Palliative Care 2Mind-Body Therapies 2Mental Status and Dementia Tests 2Heart Rate 2Gadolinium DTPA 2Exercise 2Elasticity Imaging Techniques 2Drug Therapy 2Diffusion Tensor Imaging 2Congresses as Topic 2Aminolevulinic Acid 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2vandetanib 1poly ICLC 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Glioma × Lomustine × Clear all
NCT02333513 2015-04-09

A Study to Evaluate the Safety and Effectiveness of PCV Chemotherapy in Patients With Recurrent High-grade Glioma With IDH1/2 Mutation

Hebei Yanda Hospital

Phase NA Unknown
100 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡